Carolien Maas, MSc, recently started working on her PhD at Erasmus Medical Center (EMC) and the Netherlands Comprehensive Cancer Organization (IKNL). Her research focuses on the prognosis and optimal treatment of cancer patients. Currently, she concentrates on the estimation of the life expectancy for patients with several different types of cancer. Furthermore, she collaborates to evaluate hospital differences in treatment and survival outcomes of cancer patients in the Netherlands.
Her background in Econometrics allows her to have a data-driven perspective. During her Econometrics bachelor degree at the University of Amsterdam (UvA), she broadened her knowledge by taking courses on Programming and Artificial Intelligence.
Her master degree in Business Analytics and Quantitative Marketing at Erasmus University (EUR) provided her with many data science techniques that are frequently useful in practice. The topic of her master thesis was ‘Evaluating heterogeneous treatment effect estimation in randomized clinical trials’. She evaluated several performance metrics to evaluate mathematical models designed to estimate individualized treatment effect and will publish a paper about this soon. This way, she aims to contribute to data-driven solutions to provide treatment plans tailored to fit each individual patient.
Erasmus Medical Center Rotterdam
Internal post address Na-2401
P.O. Box 2040
3000 CA Rotterdam
Visitor address:
Erasmus MC
Dr. Molewaterplein 40
3015 GD Rotterdam
Prognosis and optimal treatment of cancer patients.
Consultant for the Master Consultancy Program.
Committe member of Junior representatives MGZ (JVO) – Introduction of new employees.
Publications list
No items found
Near-normal life expectancy for patients with chronic myeloid leukemia
The loss of life expectancy in patients with chronic myeloid leukemia: a population-based study in the Netherlands, 1989-2018